Differentiation therapy
| Differentiation therapy | |
|---|---|
| Specialty | oncology |
Differentiation therapy is an approach to treating advanced cancers in which malignant cells are encouraged to differentiate into more mature forms using pharmacological agents. The basis of the therapy stems from the tendency of malignant tumor cells to assume a less specialized, stem cell-like dedifferentiated state.[1]
Leukemia[edit | edit source]
The approach was motivated by noticing that leukemia cells fail to differentiate and fully mature.[2]
By 2001 encouraging clinical results were seen.[3]
The first differentiation agent found to be successful was all-trans-retinoic acid (ATRA) in the treatment of acute promyelocytic leukemia (APL).[1]
Other cancers[edit | edit source]
The process of cancer spreading (metastasis) involves tumour cells undergoing an epithelial-to-mesenchymal transition (EMT) to invade and spread, followed by a mesenchymal-to-epithelial transition (MET) at remote sites.
Other agents investigated (pre-clinically) to encourage MET include cholera toxin (CTx) and forskolin (Fsk).[4]
References[edit | edit source]
 | This oncology article is a stub. You can help WikiMD by expanding it. |
 | This medical treatment–related article is a stub. You can help WikiMD by expanding it. |
Navigation: Wellness - Encyclopedia - Health topics - Disease Index - Drugs - World Directory - Gray's Anatomy - Keto diet - Recipes
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro) available.
Advertise on WikiMD
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.Contributors: Prab R. Tumpati, MD
